AEON Biopharma, Inc.

Historical 13F Holders

Symbol
AEON
CUSIP
00791X100
All holders as of
Q4 2024
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00791X100 since 12/18/2024, largest first.

Filer % of Class Filed
Bigger Capital Fund L P 13G
6.1% 1/8/2025
Event 1/6/2025
Robert J Palmisano 13D/A
5.7% 3/7/2025
Event 7/25/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
L1 Capital Global Opportunities Master Fund, Ltd. 13G/A 4.1% 5/15/2025
Event 3/31/2025
Blue Owl Capital Holdings LP 13G/A 3.8% 2/14/2025
Event 12/31/2024
Polar Asset Management Partners Inc. 13G/A 0% 5/15/2025
Event 3/31/2025
S.H.N. Financial Investments Ltd. 13G/A 0% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 38 8.88 M $4.80 M
2024 Q3 32 9.57 M $10.1 M
2024 Q2 28 9.43 M $8.73 M
2024 Q1 31 9.52 M $104 M
2023 Q4 25 8.69 M $57.0 M
2023 Q3 16 4.75 M $25.9 M